Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    "Chordoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Chordoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Nilotinib With Radiation for High Risk Chordoma
Condition: Chordoma
Interventions: Drug: Nilotinib;   Radiation: Radiation therapy
2 Unknown  Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
Condition: Chordoma
Intervention: Drug: Imatinib + LBH589
3 Completed Efficacy and Safety of Imatinib in Chordoma
Condition: Chordoma
Intervention: Drug: imatinib
4 Active, not recruiting Proton Beam Therapy for Chordoma Patients
Condition: Chordoma
Interventions: Radiation: Proton Beam Therapy;   Radiation: Photon Beam Therapy
5 Completed Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
Condition: Chordoma
Intervention:
6 Completed Chordoma Family Study
Condition: Chordoma
Intervention:
7 Recruiting Ion Irradiation of Sacrococcygeal Chordoma
Condition: Sacral Chordoma
Interventions: Radiation: protons;   Radiation: carbon ions
8 Recruiting The National Cancer Institute Opens A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma
Condition: Chordoma
Interventions: Other: GI-6301 Placebo;   Biological: GI-6301 Vaccine (Yeast- Brachyury);   Radiation: Radiotherapy
9 Completed Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Condition: Chordoma
Intervention: Procedure: Fluoromisonidazole-PET/CT
10 Recruiting Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers
Conditions: Skull Base Chordoma;   Vertebral Chordoma
Interventions: Procedure: Surgery;   Radiation: Protontherapy
11 Completed Proton Therapy for Chordomas and/or Chondrosarcomas
Conditions: Chordomas;   Chondrosarcomas
Intervention:
12 Recruiting Proton Radiation for Chordomas and Chondrosarcomas
Conditions: Chordomas;   Chondrosarcomas
Intervention: Radiation: Proton Therapy
13 Recruiting Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes
Conditions: Genes;   Sporadic Chordoma
Intervention:
14 Unknown  Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Conditions: Chordoma;   Chondrosarcoma
Intervention: Radiation: Charged Particle Radiation Therapy
15 Recruiting Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base
Conditions: Chordoma;   Tumor;   Treatment
Interventions: Radiation: Carbon ion;   Radiation: Protons
16 Not yet recruiting Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
Condition: Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Interventions: Radiation: Carbon ions therapy;   Radiation: Advanced external radiotherapy by Xrays or protons
17 Recruiting High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull
Conditions: Chordoma of Spine;   Chordoma of Sacrum;   Chordoma of Base of Skull;   Chondrosarcoma of the Spine;   Chondrosarcoma of the Sacrum
Intervention: Radiation: High Dose Intensity Modulated Proton Radiation
18 Recruiting A Study of IMRT in Primary Bone and Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma, Adult;   Ewing Sarcoma;   Bone Sarcoma;   Chordoma
Intervention: Radiation: Intensity modulated radiotherapy (IMRT)
19 Unknown  Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
Conditions: Brain and Central Nervous System Tumors;   Chordoma;   Kidney Cancer;   Leukemia;   Lymphoma;   Mucositis;   Neuroblastoma;   Pain;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: polyvinylpyrrolidone-sodium hyaluronate gel
20 Terminated Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Chordoma;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma
Interventions: Drug: amifostine trihydrate;   Drug: busulfan;   Drug: filgrastim;   Drug: melphalan;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation (PBSC)

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.